Certolizumab Pegol (Certolizumab Pegol)


Combined with:

Folic Acid
Methotrexate
Prednisolone

Indications and Reactions:

Role Indications Reactions
Primary
Rheumatoid Arthritis 78.2%
Crohn's Disease 17.7%
Depression 0.4%
Hypertension 0.4%
Prophylaxis 0.4%
Psoriatic Arthropathy 0.4%
Hyperlipidaemia 0.3%
Antibiotic Prophylaxis 0.2%
Arthritis 0.2%
Constipation 0.2%
Gastritis Prophylaxis 0.2%
Interstitial Lung Disease 0.2%
Osteoporosis 0.2%
Basedow's Disease 0.1%
Carotid Artery Thrombosis 0.1%
Cataract 0.1%
Cystitis 0.1%
Eyelid Ptosis 0.1%
Gastritis 0.1%
Hypercholesterolaemia 0.1%
Vomiting 11.9%
Subarachnoid Haemorrhage 9.1%
Sepsis 7.3%
White Blood Cell Count Decreased 7.3%
Urinary Tract Infection 6.4%
Pneumonia 5.9%
Pyrexia 5.9%
Staphylococcal Infection 5.5%
White Blood Cell Count Increased 5.0%
Rheumatoid Arthritis 4.1%
Uterine Leiomyoma 4.1%
Sinusitis 3.7%
Weight Decreased 3.7%
Rash 3.2%
Tuberculosis 3.2%
Condition Aggravated 2.7%
Gastroenteritis 2.7%
Headache 2.7%
Herpes Zoster 2.7%
Transient Ischaemic Attack 2.7%
Secondary
Rheumatoid Arthritis 62.5%
Diabetes Mellitus Management 12.5%
Insomnia 12.5%
Product Used For Unknown Indication 12.5%
Pyelonephritis Acute 100.0%

Drug Data